The CEO is responsible for FIT Biotech’s business management, following the Limited Liability Companies Act and the instructions, directives and authorisations by the Board of Directors, ensures that the company’s accounting is in compliance with the law and that the company’s asset management is appropriately organised.
The CEO also directs and monitors FiT Biotech’s business operations, is responsible for the day-to-day operational management and realisation of the company’s strategy, as well as prepares matters for the Board of Directors and takes responsibility of their implementation.
The CEO is nominated by the Board of Directors that also decides upon the CEO’s remuneration and other terms and conditions of the CEO’s contract. The CEO is nominated until further notice.
FIT Biotech’s CEO is James Kuo.